21-hydroxylase deficiency primary prevention
Jump to navigation
Jump to search
|
21-hydroxylase deficiency Microchapters |
|
Differentiating 21-Hydroxylase Deficiency from other Diseases |
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
21-hydroxylase deficiency primary prevention On the Web |
|
American Roentgen Ray Society Images of 21-hydroxylase deficiency primary prevention |
|
Risk calculators and risk factors for 21-hydroxylase deficiency primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mehrian Jafarizade, M.D [2]
Overview
Pre-natal diagnosis of 21-hydroxylase deficiency is established to prevent complications of the disease in future life and treated with pre-natal dexamethasone.
Primary Prevention
- Pre-natal diagnosis of 21-hydroxylase deficiency in patients with positive family history is established to prevent complications in future. A positive diagnosis is treated with prenatal dexamethasone.
- The tests available for making a pre-natal diagnosis of 21-hydroxylase deficiency include:
- Amniotic fluid testing
- Oligonucleotide hybridization of deoxyribonucleic acid (DNA) obtained from chorionic villus sampling utilizes fetal DNA extracted from maternal blood through non-invasive methods.[1]
References
- ↑ Kazmi D, Bailey J, Yau M, Abu-Amer W, Kumar A, Low M, Yuen T (2017). "New developments in prenatal diagnosis of congenital adrenal hyperplasia". J. Steroid Biochem. Mol. Biol. 165 (Pt A): 121–123. doi:10.1016/j.jsbmb.2016.06.016. PMID 27378492.